| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0098 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0038 | 1 |